Discovery could one day serve as the basis for a non-insulin based therapeutic

The Diabetes Center at CHOP aims to diminish persistent racial disparities in diabetes care by involving families, tracking treatment, follow-up care and device use, and revealing individuals’ implicit biases.  

New cases of type 2 diabetes, when the body can’t use or make enough insulin, soared in kids during the COVID-19 pandemic. Learn the signs and how CHOP can help!

CHOP researchers have shown that a targeted treatment they developed is effective at controlling blood sugar in patients with hyperinsulinism.

A community health worker helped one family learn to manage diabetes — and life.

In a study published in Diabetes Care, CHOP researchers find having youth buy-in from the beginning helps ensure consistent use of continuous glucose monitoring.

Prediabetes is a serious condition that can be managed or reversed by making healthy diet and lifestyle choices.

At Children’s Hospital of Philadelphia, multiple members of the Diabetes Center work as a team to help families manage their child’s diabetes.

A multi-center team of researchers led by Children’s Hospital of Philadelphia (CHOP) has discovered a genetic signature that could help distinguish an adult-onset form of diabetes sharing many type 1 diabetes (T1D) characteristics from pediatric-onset T1D.

As a pediatric endocrinologist, my unfortunate answer to parents perplexed by their child’s diagnosis is: “No.” Related to rising rates of obesity, the incidence of youth-onset type 2 diabetes (T2D) has been increasing by 5% annually in the United States, with the greatest increase among racial and ethnic minorities.